Keyphrases
Antitumor Activity
100%
Immune Activation
100%
EZH2 Inhibitor
100%
Urothelial Carcinoma
100%
Enhancer of Zeste Homolog 2 (EZH2)
50%
Antitumor Effect
50%
Catalytic Inhibition
50%
Small Molecules
25%
Adaptive Immune Response
25%
Tumor Progression
25%
Patient Survival
25%
Carcinogen-induced
25%
Immune Evasion
25%
Immune Infiltration
25%
Long-term Survival
25%
Histone Methyltransferase EZH2
25%
Resistance to Treatment
25%
Bladder Cancer Model
25%
Urothelium
25%
Infiltrating T Cells
25%
MHC Class II Expression
25%
Catalytic Inhibitor
25%
Innate Resistance
25%
Advanced Urothelial Carcinoma
25%
Immunology and Microbiology
Adaptive Immune System
100%
Immune Cell Infiltration
100%
Immunity
100%
Immune Evasion
100%
Long Term Survival
100%
Antineoplastic Activity
100%
MHC Class II
100%
T Cell
100%
Urothelium
100%
Biochemistry, Genetics and Molecular Biology
EZH2
100%
Immunity
100%
Antineoplastic Activity
100%
Small Molecule
16%
Adaptive Immunity
16%
Immune Evasion
16%
MHC Class II
16%
Histone Methyltransferase
16%
Long Term Survival
16%
Tumor Progression
16%
T Cell
16%